Conversely, protective effects of cathepsin H on the risk of pancreatic cancer were observed (IVW: p = 0.0410, OR = 0.9131, 95% CI = 0.8369–0.9963). This evidence concerns the gene CTSH and familial pancreatic carcinoma.